A Comparison of Two Dose Levels of Indinavir Combined With Two Nucleoside Analogue Reverse Transcriptase Inhibitors (NRTIs) in HIV-Infected Patients
Public ClinicalTrials.gov record NCT00002406. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulphate, 800 Mg q 8h Versus 1,200 Mg q 12h in HIV-Infected Individuals Having Plasma Viral RNA Less Than 400 Copies/Ml, on Concomitant Therapy With 2 Nucleoside Analogue Reverse Transcriptase Inhibitors (NRTI)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine if two dose levels of indinavir combined with two nucleoside analogue reverse transcriptase inhibitors (NRTIs) have the same effect on plasma viral load (level of HIV in the blood).
Study identification
- NCT ID
- NCT00002406
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 350 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 16 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 24, 2005
United States locations
- U.S. sites
- 29
- U.S. states
- 15
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| 1917 Research Clinic | Birmingham | Alabama | 35294 | — |
| Kaiser Permanente / Infectious Disease | Los Angeles | California | 90027 | — |
| Tower ID Med Associates | Los Angeles | California | 90048 | — |
| Ctr for AIDS Research / Education and Service (CARES) | Sacramento | California | 95814 | — |
| San Francisco Gen Hosp / UCSF AIDS Program | San Francisco | California | 94110 | — |
| HIV Clinical Research | Fort Lauderdale | Florida | 33316 | — |
| Univ of Miami School of Medicine | Miami | Florida | 33136 | — |
| AIDS Research Consortium of Atlanta | Atlanta | Georgia | 30308 | — |
| Ponce de Leon Ctr | Atlanta | Georgia | 30308 | — |
| Northwestern Univ Med School | Chicago | Illinois | 60611 | — |
| Rush Presbyterian St Lukes Med Ctr | Chicago | Illinois | 60612 | — |
| Natl Naval Med Ctr / Special Immunology Clinic | Bethesda | Maryland | 20889 | — |
| Brigham and Women's Hosp | Boston | Massachusetts | 02115 | — |
| Boston Med Ctr / Clinical Research Office | Boston | Massachusetts | 02118 | — |
| Univ Health Ctr 7D | Detroit | Michigan | 48201 | — |
| Kansas City Free Health Clinic | Kansas City | Missouri | 64111 | — |
| Education & Research Building | Camden | New Jersey | 08103 | — |
| Garden State Infectious Diseases / E I P Kennedy Health Sys | Voorhees Township | New Jersey | 08043 | — |
| Albany Med College / Div of HIV Medicine | Albany | New York | 12208 | — |
| SUNY / Health Science Ctr at Brooklyn | Brooklyn | New York | 11203 | — |
| New York Hosp of Queens / AIDS Ctr | Flushing | New York | 11355 | — |
| CRIA | New York | New York | 10001 | — |
| St Vincents Hosp and Med Ctr / Div of HIV Med | New York | New York | 10011 | — |
| Anderson Clinical Research | New York | New York | 10016 | — |
| Akron City Hospital | Akron | Ohio | 44304 | — |
| Thomas Jefferson Univ | Philadelphia | Pennsylvania | 19107 | — |
| Anderson Clinical Research | Pittsburgh | Pennsylvania | 15213 | — |
| Houston Clinical Research Network / Southhampton Med Group | Houston | Texas | 77098 | — |
| Univ of Utah School Of Medicine / Div of Infec Disease | Salt Lake City | Utah | 84132 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00002406, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 24, 2005 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00002406 live on ClinicalTrials.gov.